Helix BioPharma (HBPCF) News Today → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free HBPCF Stock Alerts $0.14 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsShort InterestStock AnalysisChartEarningsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHelix Dusk Luxe Mattress Review 2024: A Comfortable Pillow-Top Bedcnet.com - April 17 at 5:42 PMHelix BioPharma Corp. Reports Voting Resultsfinance.yahoo.com - January 22 at 12:58 PMHelix BioPharma Corp. Announces Fiscal 2024 First Quarter Resultsfinance.yahoo.com - December 14 at 7:26 PMHelix BioPharma Corp HBPmorningstar.com - November 28 at 11:29 PMHelix Biopharma GAAP EPS of -C$0.03msn.com - October 27 at 9:54 PMHelix BioPharma Corp. Announces Fiscal 2023 Year-End Resultsfinance.yahoo.com - October 27 at 9:54 PMHelix BioPharma Corp. (HBP)uk.investing.com - September 14 at 6:01 PMHELIX BIOPHARMA CORP (HBPCF) stock forecast and price targetfinance.yahoo.com - June 29 at 2:20 PMHelix Energy Up on BP Spill Contractthestreet.com - May 14 at 7:33 PMHelix Biopharma Corp. Announces Fiscal 2023 Second Quarter Resultsfinance.yahoo.com - March 15 at 6:50 PMIs Helix BioPharma (TSE:HBP) In A Good Position To Deliver On Growth Plans?finance.yahoo.com - January 31 at 7:31 AMHelix BioPharma appoints R&D headseekingalpha.com - September 3 at 9:46 PMProactive news headlines including Shell, Maverix Metals, Helix BioPharma, Wellteq Digital Health and Trees Corpbenzinga.com - September 2 at 3:43 PMHelix Biopharma Corp. Announces Appointment of New Chief Financial Officerfinance.yahoo.com - May 18 at 9:52 AMHelix BioPharma appoints Artur Gabor as its new CEO; adds three new board membersca.proactiveinvestors.com - April 18 at 2:01 PMHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscriptionfinance.yahoo.com - April 13 at 6:17 PMHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscriptionfinance.yahoo.com - April 13 at 6:17 PMHelix Biopharma GAAP EPS of -$0.01seekingalpha.com - March 18 at 7:10 AMHelix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the Boardfinance.yahoo.com - March 16 at 10:32 AMHelix Biopharma Corp. (HBPCF)nasdaq.com - January 28 at 11:33 PMHelix BioPharma Corp. Reports Voting Results and Appointment of New Board Directorfinance.yahoo.com - January 28 at 6:33 PMHelix Biopharma Corp. Announces Fiscal 2021 Year-End Resultsfinance.yahoo.com - December 9 at 7:14 PMHelix BioPharma Corp. Provides Third Bi-Weekly MCTO Status Updatefinance.yahoo.com - November 30 at 10:59 PMHelix BioPharma Corp. Announces Delay of Annual Filingsfinance.yahoo.com - October 15 at 9:09 PMHelix BioPharma Corp. Announces Delay of Annual Filingsfinance.yahoo.com - October 15 at 9:09 PM Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address The World's First "$20 Trillion Drug?" (Ad)One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%! Get the name of the stock here >>> HBPCF Media Mentions By Week HBPCF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HBPCF News Sentiment▼0.000.37▲Average Medical News Sentiment HBPCF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HBPCF Articles This Week▼00▲HBPCF Articles Average Week Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBPCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theratechnologies News Today Acurx Pharmaceuticals News Today ImmunoPrecise Antibodies News Today NRx Pharmaceuticals News Today CASI Pharmaceuticals News Today Fortress Biotech News Today Viracta Therapeutics News Today IntelGenx Technologies News Today Eyenovia News Today Unicycive Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HBPCF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.